Antibodies to Feline McDonough Sarcoma (FMS)-like tyrosine kinase 3 receptor ligand (FLT3L) and uses thereof for treating autoimmune and inflammatory diseases
US12209123B2 · kind B2 · utility
0Cited by
61References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 21, 2022 |
| Grant date | Jan 28, 2025 |
| Priority date | — |
| Expiry date | Oct 5, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are anti-FLT3L antibodies and methods of using the antibodies to treat autoimmune and other inflammatory diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.